Not exact matches
Interestingly, this influence appears to work both ways — a mild
reduction in disease
symptoms was seen
when HD mice were treated with normal glial cells.
Under an existing collaborative research arrangement, Sanofi and Immune Design have generated a large set of preclinical data demonstrating that certain formulations within GLAAS,
when given prophylactically or therapeutically, can shift the immune responses
in a way that may result
in significant protection and
reduction from allergy
symptoms.
The therapeutic dotential of dietary precursor modulation by a fish - oil - supplemented diet (n - 3 fatty acids), such as eicosapentaenoic acid (C20: 5,n - 3) and docosahexaenoic acid (C22: 6,n - 3)
in the therapy of ulcerative colitis has been shown to result
in a 35 % to 50 % decrease
in neutrophil production of LTB4.28 Significant improvement
in symptoms and histologic appearance of the rectal mucosa has been observed
in several small series of patients with Crohn's disease and ulcerative colitis given fish oil at 3 to 4 g daily for 2 to 6 months
in uncontrolled studies.29 However, a larger, randomized, double - blind trial comprising 96 patients with ulcerative colitis failed to reveal any benefit
in remission maintenance or treatment of relapse on 4.5 g of eicosapentaenoic acid daily, despite a significant
reduction in LTB4 synthesis by blood peripheral polymorphonuclear cells.30 It should be emphasized, however, that the anti-inflammatory actions of the fish oils,
in addition to inhibition of LTB4, include suppression of IL - 1 and platelet activating factor synthesis and scavenging of free oxygen radicals.30 The impact of increased lipid peroxidation after fish oil supplementation should be considered
when altering the n - 6: n - 3 fatty acid ratio.31 Antioxidant supplementation may be able to counteract the potentially adverse effects of n - 3 fatty acids.
Weight control early
in life and
reduction in weight
when symptoms occur are both important.
We also are learning that
when we eliminate or severely restrict carbohydrate matter
in the diet, dogs experience improvements
in their health including: the
reduction of inflammatory diseases such as cancer; allergies, skin, and ear issues; GI
symptoms; incontinence; behavioral issues; neurological disease; and arthritis and painful joint diseases.
When you consider the fact that most controlled outcome studies of medications or psychotherapy for depression only report roughly 50 percent
symptom reduction, on average,
in 12 to 16 weeks of treatment, those findings were encouraging.
Second, WLC children will show a similar
reduction in mood
symptoms when they receive MF - PEP 1 year after study entry.
Family therapy is often useful
when dealing with problems arising from struggling relationships within the family and can even assist
in the
reduction of
symptoms like alcohol abuse or eating disorders.
For example, Bredemeier et al. (2012) found that depressive
symptoms increase cognitive load such that experiencing depression mirrors the
reduction in cognitive ability experienced
when multi-tasking.
We found that securely attached adolescents experienced greater
reduction in internalizing
symptoms from admission to discharge, even
when controlling for length of stay.
In 1998, we conducted a randomized, controlled trial of a simple, behavioral infant sleep intervention (the Infant Sleep Study) that led to significant reductions in infant sleep problems and maternal report of depression symptoms 4 months later.10 In 2001, when the children were aged 3 to 4 years, we followed the participants of the earlier trial, all of whom had sleep problems at entry to the Infant Sleep Stud
In 1998, we conducted a randomized, controlled trial of a simple, behavioral infant sleep intervention (the Infant Sleep Study) that led to significant
reductions in infant sleep problems and maternal report of depression symptoms 4 months later.10 In 2001, when the children were aged 3 to 4 years, we followed the participants of the earlier trial, all of whom had sleep problems at entry to the Infant Sleep Stud
in infant sleep problems and maternal report of depression
symptoms 4 months later.10
In 2001, when the children were aged 3 to 4 years, we followed the participants of the earlier trial, all of whom had sleep problems at entry to the Infant Sleep Stud
In 2001,
when the children were aged 3 to 4 years, we followed the participants of the earlier trial, all of whom had sleep problems at entry to the Infant Sleep Study.